Fantastic news....key thing is this, from the announcement......Extremely exciting when the company has this capacity for accelerated approval in a major cancer such as Brain Mets, where there is virtually no competition. US55m market cap crazy.
"drugs with FTD may be eligible for Accelerated Approval, in which a new medicine is approved prior to the availability of definitive data,"
Ann: Kazia's paxalisib granted Fast Track Designation by FDA, page-2
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)